About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Kidney Disease Clinical Trials in Phoenix | 68 Studies

Clinical Trials Kidney DiseasePhoenix

Kidney Disease Clinical Trials in Phoenix

Find 68 clinical trials for kidney disease near Phoenix, Arizona. Connect with research centers in your area.

All Kidney Disease trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 68 trials

CompletedSafety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on DialysisThe purpose of this study was to evaluate the safety and efficacy of peginesatide for the treatment of anemia in participants with chronic kidney disease, who are not on dialysis…NCT00598442·Phoenix, Arizona and 63 others

Kidney Disease Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedHead to Head Study Against Sevelamer HydrochlorideTo compare the efficacy of Fosrenol (Lanthanum carbonate) and sevelamer hydrochloride in the reduction of serum phosphorus levels from baseline.NCT00441545·Mesa, Arizona and 43 others

Active not recruitingA Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.The purpose of this study is to measure the efficacy and safety of baxdrostat/dapagliflozin in participants ≥ 18 years of age with CKD and HTN.NCT06268873·Fairhope, Alabama and 564 others

RecruitingAmerican Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)Despite many advances in our understanding of the natural history and progression of chronic kidney disease (CKD) and cardio vascular disease (CVD) in the parent CRIC study over…NCT04185844·Phoenix, Arizona and 2 others

CompletedFolic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)The purpose of this randomized clinical trial is to determine if lowering homocysteine levels in renal transplant recipients with a multivitamin will reduce the occurrence of…NCT00064753·Birmingham, Alabama and 29 others

CompletedStrategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney DiseaseA phase 3, multicenter, randomized, double-blind, parallel group study.NCT01652872·Anniston, Alabama and 248 others

CompletedAnemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)The purpose of this multi-center event-driven study in non-dialysis (ND) participants with anemia associated with chronic kidney disease (CKD) is to evaluate the safety and…NCT02876835·Andalusia, Alabama and 573 others

TerminatedStudy of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) NephropathyThe primary objective of this study is to evaluate the effect of OMS721 on 24-hour urine protein excretion (UPE) in IgA nephropathy (IgAN) patients with high baseline proteinuria…NCT03608033·Florence, Alabama and 138 others

CompletedA Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular RiskThe main purpose of this study is to determine safety and efficacy of orforglipron compared with insulin glargine in participants with type 2 diabetes and obesity or overweight at…NCT05803421·Daphne, Alabama and 357 others

TerminatedSafety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDISafety, Efficacy, PK and PD of CTAP101 (calcifediol) ER Capsules for SHPT in HD Patients VDINCT03602261·Peoria, Arizona and 17 others

TerminatedA Study in Participants With Diabetic Kidney DiseaseThe purpose of this study is to determine if LY2382770 is safe and effective at protecting kidney function in participants with kidney disease due to diabetes.NCT01113801·Phoenix, Arizona and 77 others

CompletedKRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)The objectives of this study are to assess the long-term efficacy and safety of different dose regimens of KRX-0502 in the treatment of iron deficiency anemia (IDA) in adult…NCT03236246·Phoenix, Arizona and 27 others

CompletedA Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney DiseaseResearchers are looking for a better way to treat people who have non-diabetic chronic kidney disease (non-diabetic CKD).NCT05047263·Huntsville, Alabama and 325 others

RecruitingA Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal DiseaseThe goal of the CSP-2002 clinical trial is to evaluate the safety and effectiveness of the InnAVasc Arteriovenous Graft (IG) for hemodialysis (HD) access in patients with…NCT04671771·Phoenix, Arizona and 20 others

CompletedEfficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney DiseaseThe primary objective of this study was to demonstrate whether, in addition to standard of care, finerenone is superior to placebo in delaying the progression of kidney disease…NCT02540993·Birmingham, Alabama and 977 others

CompletedSafety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on HemodialysisThe purpose of this study was to evaluate the safety and efficacy of peginesatide in the maintenance treatment of anemia in participants on dialysis.NCT00597584·Phoenix, Arizona and 83 others

CompletedThe PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4To evaluate the effects of paricalcitol capsules on cardiac structure and function over 48 weeks in patients with Stage 3/4 chronic kidney disease (CKD) who had left ventricular…NCT00497146·Phoenix, Arizona and 70 others

TerminatedAn Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE)This extended access study will assess the long-term safety and tolerability of bardoxolone methyl in qualified patients with chronic kidney disease (CKD) who previously…NCT03749447·Birmingham, Alabama and 86 others

CompletedTrial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula OutcomesThe objective of this study is to evaluate efficacy and safety outcomes following use of the Sirolimus-eluting Collagen Implant (SeCI) in subjects undergoing surgical creation of…NCT02513303·Huntsville, Alabama and 3 others

CompletedKRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKDa 24-week phase 3, multi-center clinical trial, comprised of a 16-week, randomized, double-blind, placebo-controlled period ("Randomized Period"), followed by an 8-week open-label…NCT02268994·Phoenix, Arizona and 35 others

PreviousPage 2 of 4Next

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia